Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

Keyphrases

• Acute Lymphoblastic Leukemia Cells 100%
• Prednisolone 100%
• Prednisolone Resistance 100%
• Glycolysis Inhibition 100%
• Glucocorticoid Resistance 42%
• Acute Lymphoblastic Leukemia 28%
• 2-Deoxy-D-glucose (2-DG) 28%
• Differentially Expressed 14%
• Pediatric Acute Lymphoblastic Leukemia 14%
• RNA Interference 14%
• Daunorubicin 14%
• Leukemia Cell Lines 14%
• Glycolysis 14%
• Glucose Metabolism 14%
• Treatment Failure 14%
• B-lineage 14%
• 3-bromopyruvate 14%
• GAPDH 14%
• Sensitizing Effect 14%
• Lonidamine 14%
• Antileukemic Drugs 14%
• Jurkat Cells 14%
• In Vitro Sensitivity 14%
• Leukemic Patients 14%
• Glycolytic Inhibitors 14%
• Glycolytic Pathway 14%
• Glycolysis Inhibitors 14%
• Glucose Consumption 14%
• MOLT-4 Cells 14%
• Cell Resistance 14%
• Drug Cytotoxicity 14%

Immunology and Microbiology

• Leukemia Cell 100%
• Prednisolone 100%
• Glycolysis 100%
• Glucocorticoid 60%
• Glucose 30%
• Cell Line 20%
• Precursor 10%
• Lineages 10%
• Leukemia Cell Line 10%
• Downregulation 10%
• Glucose Metabolism 10%
• Drug Cytotoxicity 10%
• RNAI 10%
• In Vitro 10%

Biochemistry, Genetics and Molecular Biology

• Prednisolone 100%
• Glycolysis 100%
• Glucocorticoid 60%
• 2-Deoxy-D-Glucose 20%
• Precursor 10%
• Downregulation 10%
• Glucose Metabolism 10%
• Daunorubicin 10%
• Drug Cytotoxicity 10%
• RNAI 10%
• Pediatrics 10%
• Glucose 10%